THAR•benzinga•
Tharimmune Expanded Its Product Pipeline With HS1940, A Dual-target Multispecific Biologic Engineered To Bind To Both Programmed Death-1 And Vascular Endothelial Growth Factor Receptors
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 4, 2025 by benzinga